277 related articles for article (PubMed ID: 30531240)
21. Pancreatic cancer early detection: expanding higher-risk group with clinical and metabolomics parameters.
Urayama S
World J Gastroenterol; 2015 Feb; 21(6):1707-17. PubMed ID: 25684935
[TBL] [Abstract][Full Text] [Related]
22. Exploring the potential of exosomes in diagnosis and drug delivery for pancreatic ductal adenocarcinoma.
Xu B; Chen Y; Peng M; Zheng JH; Zuo C
Int J Cancer; 2023 Jan; 152(2):110-122. PubMed ID: 35765844
[TBL] [Abstract][Full Text] [Related]
23. Linc00675 is a novel marker of short survival and recurrence in patients with pancreatic ductal adenocarcinoma.
Li DD; Fu ZQ; Lin Q; Zhou Y; Zhou QB; Li ZH; Tan LP; Chen RF; Liu YM
World J Gastroenterol; 2015 Aug; 21(31):9348-57. PubMed ID: 26309360
[TBL] [Abstract][Full Text] [Related]
24. Nestin and other putative cancer stem cell markers in pancreatic cancer.
Matsuda Y; Kure S; Ishiwata T
Med Mol Morphol; 2012 Jun; 45(2):59-65. PubMed ID: 22718289
[TBL] [Abstract][Full Text] [Related]
25. Dkk1 involvement and its potential as a biomarker in pancreatic ductal adenocarcinoma.
Igbinigie E; Guo F; Jiang SW; Kelley C; Li J
Clin Chim Acta; 2019 Jan; 488():226-234. PubMed ID: 30452897
[TBL] [Abstract][Full Text] [Related]
26. Circulating Exosomes in Pancreatic Cancer: Will They Succeed on the Long, Littered Road to Early Detection Marker?
Babic A; Wolpin BM
Clin Chem; 2016 Feb; 62(2):307-9. PubMed ID: 26721295
[No Abstract] [Full Text] [Related]
27. Pancreatic cancer stem cells: features and detection methods.
Ishiwata T; Matsuda Y; Yoshimura H; Sasaki N; Ishiwata S; Ishikawa N; Takubo K; Arai T; Aida J
Pathol Oncol Res; 2018 Oct; 24(4):797-805. PubMed ID: 29948612
[TBL] [Abstract][Full Text] [Related]
28. Exosomes, metastases, and the miracle of cancer stem cell markers.
Wang Z; Zöller M
Cancer Metastasis Rev; 2019 Jun; 38(1-2):259-295. PubMed ID: 31030373
[TBL] [Abstract][Full Text] [Related]
29. FOXC2 is up-regulated in pancreatic ductal adenocarcinoma and promotes the growth and migration of cancer cells.
Cui L; Dang S; Qu J; Mao Z; Wang X; Zhang J; Chen J
Tumour Biol; 2016 Jul; 37(7):8579-85. PubMed ID: 26733175
[TBL] [Abstract][Full Text] [Related]
30. The Proteome of Pancreatic Cancer-Derived Exosomes Reveals Signatures Rich in Key Signaling Pathways.
Han S; Huo Z; Nguyen K; Zhu F; Underwood PW; Basso KBG; George TJ; Hughes SJ
Proteomics; 2019 Jul; 19(13):e1800394. PubMed ID: 31070281
[TBL] [Abstract][Full Text] [Related]
31. Glypican-3 and KRT19 are markers associating with metastasis and poor prognosis of pancreatic ductal adenocarcinoma.
Yao H; Yang Z; Liu Z; Miao X; Yang L; Li D; Zou Q; Yuan Y
Cancer Biomark; 2016; 17(4):397-404. PubMed ID: 27689616
[TBL] [Abstract][Full Text] [Related]
32. Primary and Metastatic Pancreatic Cancer Cells Exhibit Differential Migratory Potentials.
Park JK; Hank T; Scherber CM; Lillemoe KD; Fernández-Del Castillo C; Warshaw AL; Toner M; Irimia D; Thayer SP; Liss AS
Pancreas; 2020 Jan; 49(1):128-134. PubMed ID: 31856088
[TBL] [Abstract][Full Text] [Related]
33. Exosomal ROR1 in peritoneal fluid identifies peritoneal disseminated PDAC and is associated with poor survival.
Mittelstädt A; Anthuber A; David P; Podolska M; Bénard A; Brunner M; Krautz C; Jacobsen A; Denz A; Weber K; Merkel S; Hackner D; Buniatov T; Roßdeutsch L; Klösch B; Swierzy I; Hansen FJ; Strobel D; Zopf Y; Baur JO; Van Deun J; Immanuel Geppert C; Gießl A; Lettmaier S; Semrau S; Grützmann R; Kouhestani D; Weber GF
Front Immunol; 2024; 15():1253072. PubMed ID: 38846943
[TBL] [Abstract][Full Text] [Related]
34. Pancreatic cancer stem cell markers and exosomes - the incentive push.
Heiler S; Wang Z; Zöller M
World J Gastroenterol; 2016 Jul; 22(26):5971-6007. PubMed ID: 27468191
[TBL] [Abstract][Full Text] [Related]
35. Exosomes: potential for early detection in pancreatic cancer.
Lu L; Risch HA
Future Oncol; 2016; 12(8):1081-90. PubMed ID: 26860951
[TBL] [Abstract][Full Text] [Related]
36. Overexpression of PD2 leads to increased tumorigenicity and metastasis in pancreatic ductal adenocarcinoma.
Vaz AP; Deb S; Rachagani S; Dey P; Muniyan S; Lakshmanan I; Karmakar S; Smith L; Johansson S; Lele S; Ouellette M; Ponnusamy MP; Batra SK
Oncotarget; 2016 Jan; 7(3):3317-31. PubMed ID: 26689992
[TBL] [Abstract][Full Text] [Related]
37. Signaling Networks That Control Cellular Plasticity in Pancreatic Tumorigenesis, Progression, and Metastasis.
Crawford HC; Pasca di Magliano M; Banerjee S
Gastroenterology; 2019 May; 156(7):2073-2084. PubMed ID: 30716326
[TBL] [Abstract][Full Text] [Related]
38. High STMN1 Expression Is Associated with Tumor Differentiation and Metastasis in Clinical Patients with Pancreatic Cancer.
Suzuki K; Watanabe A; Araki K; Yokobori T; Harimoto N; Gantumur D; Hagiwara K; Yamanaka T; Ishii N; Tsukagoshi M; Igarashi T; Kubo N; Gombodorj N; Nishiyama M; Hosouchi Y; Kuwano H; Shirabe K
Anticancer Res; 2018 Feb; 38(2):939-944. PubMed ID: 29374725
[TBL] [Abstract][Full Text] [Related]
39. UNR/CDSE1 expression as prognosis biomarker in resectable pancreatic ductal adenocarcinoma patients: A proof-of-concept.
Martinez-Useros J; Georgiev-Hristov T; Fernández-Aceñero MJ; Borrero-Palacios A; Indacochea A; Guerrero S; Li W; Cebrián A; Gómez Del Pulgar T; Puime-Otin A; Del Puerto-Nevado L; Rodríguez-Remírez M; Pérez N; Celdrán A; Gebauer F; Garcia-Foncillas J
PLoS One; 2017; 12(8):e0182044. PubMed ID: 28763470
[TBL] [Abstract][Full Text] [Related]
40. Pancreatic Cancer: Current Progress and Future Challenges.
Hussain SP
Int J Biol Sci; 2016; 12(3):270-2. PubMed ID: 26929733
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]